Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
| ▸ | VCP | P55072 | 2/20 | 0.45 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.45 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.45 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.45 |
| ▸ | TAS2R14 | Q9NYV8 | 2/20 | 0.45 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | PTGIR | P43119 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4652521 | 0.99 | KMT2A (0.53) | KMT2AALDH1A1MEN1CYP2C9GAA | |
| SCHEMBL594857 | 0.87 | ALDH1A1 (0.67) | KMT2AALDH1A1MEN1CYP2C9GAA | |
| SCHEMBL594858 | 0.87 | ALDH1A1 (0.67) | KMT2AALDH1A1MEN1CYP2C9GAA | |
| SCHEMBL4652516 | 0.86 | ALDH1A1 (0.50) | KMT2AALDH1A1MEN1CYP2C9GAA | |
| SCHEMBL4797282 | 0.86 | ALDH1A1 (0.52) | KMT2AALDH1A1MEN1CYP2C9GAA | |
| SCHEMBL4795836 | 0.86 | ALDH1A1 (0.52) | KMT2AALDH1A1MEN1CYP2C9GAA | |
| SCHEMBL4654803 | 0.86 | ALDH1A1 (0.65) | KMT2AALDH1A1MEN1CYP2C9GAA | |
| Ammonia Solution, Strong SCHEMBL4804478 | 0.83 | VCP (0.49) | ALDH1A1GAAVCPTPSAB1TPSD1 | |
| SCHEMBL10639382 | 0.82 | VCP (0.50) | ALDH1A1GAAVCPTPSAB1TPSD1 | |
| SCHEMBL4798640 | 0.82 | VCP (0.50) | ALDH1A1GAAVCPTPSAB1TPSD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060018867-A1 | Cosmetic composition and production thereof | ICHIMARU PHARCOS CO., LTD | 2006-01-26 | — | — | US | disclosed |
| EP-1604647-A1 | Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof | Ichimaru Pharcos Co., Ltd. (JP) | 2005-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060018867-A1 | Cosmetic composition and production thereof | CUTA, PARG, TYR | KMT2A 847/4885ALDH1A1 1854/4885MEN1 1028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.